Robert I. Blum
President & CEO at Cytokinetics Incorporated
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cytokinetics Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytokinetics Incorporated May 15, 202497.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Cytokinetics Incorporated | Open-market sale | −97,926 | $69.33 | $6,789,210 |
| Sep 14, 2026 | Cytokinetics Incorporated | Option exercise | +7,500 | $10.60 | $79,500 |
| Sep 14, 2026 | Cytokinetics Incorporated | Open-market sale | −7,500 | $73.44 | $550,800 |
| Sep 14, 2026 | Cytokinetics Incorporated | Gift | −1,350 | — | — |
| Sep 14, 2026 | Cytokinetics Incorporated | Gift | −97,926 | — | — |
| Sep 14, 2026 | Cytokinetics Incorporated | Gift | +97,926 | — | — |
| Aug 31, 2026 | Cytokinetics Incorporated | Option exercise | +7,500 | $10.60 | $79,500 |
| Aug 31, 2026 | Cytokinetics Incorporated | Open-market sale | −7,500 | $70.24 | $526,800 |
| Aug 10, 2026 | Cytokinetics Incorporated | Option exercise | +7,500 | $10.60 | $79,500 |
| Aug 10, 2026 | Cytokinetics Incorporated | Open-market sale | −7,500 | $76.76 | $575,700 |
| Jul 27, 2026 | Cytokinetics Incorporated | Option exercise | +7,500 | $10.60 | $79,500 |
| Jul 27, 2026 | Cytokinetics Incorporated | Open-market sale | −7,500 | $80.87 | $606,525 |
| Jul 13, 2026 | Cytokinetics Incorporated | Open-market sale | −10 | $82.02 | $820 |
| Jul 13, 2026 | Cytokinetics Incorporated | Option exercise | +7,490 | $10.60 | $79,394 |
| Jul 13, 2026 | Cytokinetics Incorporated | Open-market sale | −7,490 | $82.02 | $614,330 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.